De inhoud van deze pagina is gebaseerd op internationale richtlijnen en recente wetenschappelijke literatuur, aangevuld met inzichten uit de klinische praktijk.
De kennisbank wordt periodiek herzien en waar nodig aangepast op basis van nieuwe inzichten.
1. Nederlands Huisartsen Genootschap. NHG-Standaard Problematisch alcoholgebruik. Utrecht: NHG; 2021.
2. Trimbos Instituut. Nationale Drug Monitor: Jaarbericht 2024. Utrecht: Trimbos-instituut; 2024.
3. Federatie Medisch Specialisten. Stoornissen in het gebruik van alcohol: screening, classificatie, diagnostiek en behandeling. Utrecht: Richtlijnendatabase; 2024.
4. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence (NG209). London: NICE; 2021.
5. National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115). London: NICE; 2011 (updated 2019).
6. Health Canada. Canadian Drugs and Substances Strategy. Ottawa: Health Canada; 2023.
7. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2018;392(10152):1015–1035.
8. Rehm J, Gmel GE Sr, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction. 2017;112(6):968–1001.
9. Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. The Lancet Public Health. 2017;2(2):e108–e120.
10. UK Office for Health Improvement and Disparities. Alcohol and drug misuse prevention and treatment guidance. London: OHID; 2022.
11. U.S. Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. Atlanta (GA): HHS; 2020.
12. Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, Fanshawe TR, Lindson N. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews. 2021;1(1):CD013752.
13. Banks E, Joshy G, Weber MF, Liu B, Grenfell R, Egger S, et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Medicine. 2020;18(1):300.
14. Canadian Centre on Substance Use and Addiction. Canada’s Guidance on Alcohol and Health. Ottawa: CCSA; 2023.
15. Centers for Disease Control and Prevention. Health Effects of Cigarette Smoking. Atlanta (GA): CDC; 2024.
16. Rumgay H, Shield KD, Charvat H, Ferrari P, Sornpaisarn B, Obot I, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. The Lancet Oncology. 2021;22(8):1071–1080.
17. Livingstone-Banks J, Ordóñez-Mena JM, Hartmann-Boyce J. Behavioural interventions for smoking cessation. Addiction. 2024;119(5):890–902.
18. U.S. Department of Health and Human Services. Alcohol and Cancer Risk: The Surgeon General’s Advisory. Washington (DC): HHS; 2025.